Cutaneous Lymphoma Annual Conference June 18-19

Registration is open for the Cutaneous Lymphoma Foundation’s (CLF) Virtual 2021 Annual Conference, June 18-19. To be clear, the annual conference is real, but it’s being delivered and attended online, i.e. in the virtual world. LOL If you or a loved one are affected by any of the cutaneous lymphomas or lymphomas with expression in…… Continue reading Cutaneous Lymphoma Annual Conference June 18-19

Lacutamab Clinical Trial for Certain CTCL Patients

Innate Pharma has recently announced phase 2 of a clinical trial dubbed TELLOMAK regarding the investigative drug lacutamab (IPH4102), an anti-KIR3DL2 monoclonal antibody, alone or in combination with chemo. The focus of this study is the treatment of patients with the rare cutaneous t-cell lymphoma (CTCL) Mycosis Fungoides and it’s systemic comparable Sézary Syndrome. The…… Continue reading Lacutamab Clinical Trial for Certain CTCL Patients

Cutaneous Lymphoma: Later Stage Treatments Webinar

Coming up Friday, April 16, at 6:00 pm EDT the Cutaneous Lymphoma Foundation (CLF) will hold an online webinar via Zoom discussing later stage treatments for this group of cancers. If you have CTCL, cutaneous b-cell lymphoma, any of the other cuteneous lymphomas, or one of the systemic cancers which manifests in the skin, the…… Continue reading Cutaneous Lymphoma: Later Stage Treatments Webinar